How much funding has Exscientia raised?

Exscientia has raised $351.0M in total funding, most recently a Series D round.

Who are Exscientia's investors?

Exscientia's investors include GT Healthcare Capital, Novo Holdings A/S, Recursion Pharmaceuticals, SoftBank, BlackRock Innovation Capital, Celgene Corporation.

When was Exscientia founded?

Exscientia was founded in 2012.

Where is Exscientia headquartered?

Exscientia is headquartered in Oxford, United Kingdom.

What industry is Exscientia in?

Exscientia operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does Exscientia have?

Exscientia has 201-500 employees.

Exscientia

Acquired

Pioneering AI Drug Discovery | Recursion

Oxford, United Kingdom · Founded 2012 · $351.0M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: Oxford
Employees: 201–500
Founded: 2012
Business Model: B2B

Website: exscientia.ai
Total Funding: $351.0M
Last Round: $225.0M Series DApr 2021
Rounds: 4

About

Exscientia was an Oxford-based AI-driven pharmatech company pioneering the automation of drug discovery and design. Founded in 2012, it was the first company to advance AI-designed drug molecules into human clinical trials. Exscientia was acquired by Recursion Pharmaceuticals in 2024 for approximately $688 million.

Summary

Exscientia is an Artificial Intelligence company based in Oxford, United Kingdom, founded in 2012. It has raised $351.0M in total across 4 rounds, most recently a $225.0M Series D round in Apr 2021. Investors include GT Healthcare Capital, Novo Holdings A/S and Recursion Pharmaceuticals.

LinkedIn X (Twitter)